Ultrasound Evaluation of Crohn's Disease

• Status: Terminated
• Trial end date: 2021-10-12
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the effectiveness of a new ultrasound technology for evaluating Crohn's disease.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mayo Clinic

Criteria

Inclusion Criteria:

• Crohn's disease patients with involvement of terminal ileum (thickness > 3mm).

Exclusion Criteria:

• Patients with change of medicine or going to surgery over the 6-months follow-up period.

• Patients with unreliable ultrasound images due to conditions such as large body habitus or poor ultrasound imaging window.

• Adults lacking capacity to consent.

• Vulnerable subjects such as prisoners.

• Pregnant women and nursing mothers.

• Patients with known or suspected right-to-left, bi-directional, or transient right-to-left cardiac shunts.

• Patients with history of hypersensitivity allergic reactions to ultrasound contrast agents.